Cadian Capital Management’s Guardant Health GH Stock Holding History

Cadian Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114M	Sell	757,393 -22,255	-3%	-$2.42M	8.6%	2
2026 Q1	$72M	Sell	779,648 -142,980	-15%	-$14.4M	8.77%	4
2025 Q4	$94.2M	Sell	922,628 -1,218,563	-57%	-$109M	6.81%	5
2025 Q3	$134M	Sell	2,141,191 -1,038,026	-33%	-$56.5M	7.95%	4
2025 Q2	$165M	Sell	3,179,217 -1,415,870	-31%	-$63.2M	9.27%	2
2025 Q1	$196M	Sell	4,595,087 -626,478	-12%	-$27M	8.38%	2
2024 Q4	$160M	Sell	5,221,565 -1,708,909	-25%	-$48.1M	9.19%	2
2024 Q3	$159M	Buy	6,930,474 +3,798,666	+121%	+$108M	8.14%	4
2024 Q2	$90.4M	Sell	3,131,808 -2,660,971	-46%	-$62M	4.5%	10
2024 Q1	$120M	Buy	5,792,779 +5,082,779	+716%	+$109M	4.25%	10
2023 Q4	$19.2M	Buy	+710,000	New	+$18.6M	0.77%	23

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cadian Capital Management's GH Position: Q2 2026 in Review

Cadian Capital Management reduced its Guardant Health (GH) stake by 2.9% in Q2 2026, selling an estimated $2.42M and leaving 757,393 shares worth $114M. The position accounts for 8.6% of the portfolio, ranked #2.

Cadian Capital Management first reported a position in GH in Q4 2023 and has held it in 11 quarters since. The position peaked at $196M in Q1 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Cadian Capital Management held 757,393 shares of Guardant Health worth $114M as of Q2 2026.
Cadian Capital Management sold 22,255 Guardant Health shares in Q2 2026, an estimated $2.42M.
Guardant Health made up 8.6% of Cadian Capital Management's portfolio in Q2 2026, its #2 holding.
Cadian Capital Management first reported a position in Guardant Health in Q4 2023 and has held it in 11 quarters since.
Cadian Capital Management's Guardant Health position peaked at $196M in Q1 2025.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Cadian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.